Everolimus quantification in peripheral blood mononuclear cells using ultra high performance liquid chromatography tandem mass spectrometry

Journal of Pharmaceutical and Biomedical Analysis

Volumn 66, Issue , 2012, Pages 278-281

  Roullet Renoleau, Francois ^a   Lemaitre, Florian ^a   Antignac, Marie ^b   Zahr, Noel ^c   Farinotti, Robert ^a   Fernandez, Christine ^a,b  

^a EA4123   (France)

^b HÔPITAL SAINT ANTOINE   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Everolimus; Liquid chromatography tandem mass spectrometry; Peripheral blood mononuclear cells; Therapeutic drug monitoring

Indexed keywords

AMMONIUM ACETATE; EVEROLIMUS; FORMIC ACID; METHANOL; WATER;

ARTICLE; BLOOD SAMPLING; CELL LEVEL; COLUMN CHROMATOGRAPHY; DRUG DETERMINATION; FLOW RATE; HUMAN; HUMAN CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRECIPITATION; PRIORITY JOURNAL; QUALITY CONTROL; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOCYTES, MONONUCLEAR; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SIROLIMUS; TANDEM MASS SPECTROMETRY;

EID: 84861223638     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2012.03.042     Document Type: Article

References (13)

1. Kirchner G.I., Meier-Wiedenbach I., Manns M.P. Clinical pharmacokinetics of everolimus. Clin. Pharmacokinet. 2004, 43:83-95.
2. Capron A., Mourad M., De Meyer M., De Pauw L., Eddour D.C., Latinne D., Elens L., Haufroid V., Wallemacq P. CYP3A5 and ABCB1 polymorphisms influence tacrolimus concentrations in peripheral blood mononuclear cells after renal transplantation. Pharmacogenomics 2010, 11:703-714.
3. Eichelbaum M., Fromm M.F., Schwab M. Clinical aspects of the MDR1 (ABCB1) gene polymorphism. Ther. Drug Monit. 2004, 26:180-185.
4. Ansermot N., Fathi M., Veuthey J.L., Desmeules J., Hochstrasser D., Rudaz S. Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approach. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2007, 857:92-99.
5. Capron A., Musuamba F., Latinne D., Mourad M., Lerut J., Haufroid V., Wallemacq P.E. Validation of a liquid chromatography-mass spectrometric assay for tacrolimus in peripheral blood mononuclear cells. Ther. Drug Monit. 2009, 31:178-186.
6. International Conference of Harmonization, Q2A Text on Validation of Analytical Procedures, March 1995.
7. International Conference of Harmonization, Q2B Validation of Analytical Procedures: Methodology, May 1997, vol. 4, 2010, pp. 413-419.
8. Sallustio B.C., Noll B.D., Morris R.G. Comparison of blood sirolimus, tacrolimus and everolimus concentrations measured by LC-MS/MS, HPLC-UV and immunoassay methods. Clin. Biochem. 2011, 44:231-236.
9. Batiuk T.D., Pazderka F., Enns J., DeCastro L., Halloran P.F. Cyclosporine inhibition of calcineurin activity in human leukocytes in vivo is rapidly reversible. J. Clin. Invest. 1995, 96:1254-1260.
10. Falck P., Asberg A., Guldseth H., Bremer S., Akhlaghi F., Reubsaet J.L., Pfeffer P., Hartmann A., Midtvedt K. Declining intracellular T-lymphocyte concentration of cyclosporine a precedes acute rejection in kidney transplant recipients. Transplantation 2008, 85:179-184.
11. Crettol S., Venetz J.P., Fontana M., Aubert J.D., Ansermot N., Fathi M., Pascual M., Eap C.B. Influence of ABCB1 genetic polymorphisms on cyclosporine intracellular concentration in transplant recipients. Pharmacogen. Genomics 2008, 18:307-315.
12. Ansermot N., Rebsamen M., Chabert J., Fathi M., Gex-Fabry M., Daali Y., Besson M., Rossier M., Rudaz S., Hochstrasser D., Dayer P., Desmeules J. Influence of ABCB1 gene polymorphisms and P-glycoprotein activity on cyclosporine pharmacokinetics in peripheral blood mononuclear cells in healthy volunteers. Drug Metab. Lett. 2008, 2:76-82.
13. Barbari A.G., Masri M.A., Stephan A.G., Mourad N., El-Ghoul B B., Kamel G.S., Kilani H.E., Karam A.S. Cyclosporine lymphocyte maximum level: a new alternative for cyclosporine monitoring in kidney transplantation. Exp. Clin. Transplant. 2005, 1:293-300.